220100.Kq
220100.KQ operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
Business. 220100.KQ operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
220100.KQ operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.17, indicating a conservative leverage position compared to industry norms. However, the company's liquidity is rated as medium, with a current ratio of 2.37, suggesting it has sufficient short-term assets to cover its liabilities, but not in excess. The company's cash and equivalents are negative at -11,462,750 KRW, and its operating cash flow is negative at -2,427,218,230 KRW, signaling potential liquidity constraints.
Profitability metrics are concerning, with a return on equity of -20.59% and a return on assets of -15.1%, both significantly below the industry median. The company reported a net loss of 11,251,212,300 KRW and an operating loss of 8,329,989,320 KRW, indicating a challenging operating environment. These figures suggest the company is underperforming relative to its peers in terms of generating returns for shareholders and utilizing assets efficiently.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases the company's exposure to sector-specific risks and regional economic fluctuations.
The company's growth trajectory is negative, with a significant decline in revenue and profitability. The outlook for the current fiscal year indicates a continuation of this trend, with no positive revenue growth expected. The company's capital expenditures are also negative at -8,527,549,450 KRW, suggesting a reduction in investment in long-term assets, which could impact future growth potential.
Risk factors include a medium liquidity risk due to negative cash and equivalents and a negative operating cash flow. The company's dilution risk is rated as low, with no significant dilution expected in the near term. However, the company's negative net income and operating income suggest a high operational risk, which could affect its ability to meet financial obligations and sustain operations.
Recent events, as disclosed in the latest financial filings, include a significant net loss and a negative operating cash flow. The company has not issued any new shares recently, and there are no indications of upcoming dilutive events. The company's financial health is further complicated by its negative free cash flow of -14,578,286,030 KRW, which limits its ability to fund operations and invest in growth opportunities.
- The company is operating at a significant net loss and has negative cash and equivalents, indicating liquidity constraints.
- The company's return on equity and return on assets are well below industry medians, suggesting poor profitability.
- The company's capital expenditures are negative, indicating a reduction in investment in long-term assets.
- The company's liquidity risk is medium, and its operational risk is high due to negative operating and net income.
- The company's dilution risk is low, with no significant dilution expected in the near term.
- The company's financial health is further complicated by a negative free cash flow, limiting its ability to fund operations and invest in growth.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 220100.KQ Market data — financials · 2026-05-26
Ownership & reference
Leadership
- Dae Yun JiPresident, Chief Executive Officer, Director